Menu Close

Articles on beta amyloid plaques

Displaying all articles

Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Family members often become primary caregivers for loved ones with Alzheimer’s disease. tonkid/Shutterstock.com

The two obstacles that are holding back Alzheimer’s research

The first clinical trial examining a drug to treat Alzheimer’s was begun 30 years ago. There is still no cure and no known way to prevent the disease. Two factors may contribute to that.
A bottlenose dolphin leaping from the ocean in Panama. Christian Wittman/Shutterstock.com

Researchers find pathological signs of Alzheimer’s in dolphins, whose brains are much like humans’

Researchers have found evidence of the same brain pathologies in dolphins that are present in the brains of humans who died with Alzheimer’s. What might this suggest about Alzheimer’s in humans?

Top contributors

More